Previous close | 130.54 |
Open | 130.92 |
Bid | 130.62 x 900 |
Ask | 131.49 x 800 |
Day's range | 130.19 - 131.50 |
52-week range | 76.58 - 131.50 |
Volume | |
Avg. volume | 834,736 |
Market cap | 17.701B |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 91.03 |
EPS (TTM) | 1.44 |
Earnings date | 30 Apr 2024 - 06 May 2024 |
Forward dividend & yield | 1.52 (1.16%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | 138.64 |
Two Leidos-designed uncrewed and autonomous-capable low-profile vessels (LPVs) recently participated in the Project Convergence Capstone 4 military exercises in California. Leidos (NYSE: LDOS), a Fortune® 500 innovation company, delivered the vessels to the U.S. Marine Corps last year.
The Leidos Partnership for Defense Health (LPDH) today announced it successfully deployed the Federal Electronic Health Record (EHR) system – which the Department of Defense calls MHS GENESIS – at the Captain James A. Lovell Federal Health Care Center (Lovell FHCC) as part of a first-of-its-kind joint Department of Defense (DOD)-Department of Veterans Affairs (VA) EHR implementation. After nearly two dozen wave deployments over the last five years, the Lovell FHCC deployment achieves 100% deploy
LDOS vs. LMT: Which Stock Is the Better Value Option?